Stay updated on Remibrutinib Long-term Extension in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Remibrutinib Long-term Extension in Urticaria Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:16:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:44:40.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with a generic error screen. This blocks access to the trial details that were previously visible on the page.
    Difference
    17%
    Check dated 2026-09-21T22:12:31.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, signaling a minor update to the page's revision history. This change reflects a backend or presentation update rather than any alteration to study details or participant information.
    Difference
    0.0%
    Check dated 2026-08-31T17:37:31.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a small platform update.
    Difference
    0.0%
    Check dated 2026-08-10T13:31:18.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces the previous v3.6.3 on the page, indicating a new build. The update does not change displayed information or layout.
    Difference
    0.0%
    Check dated 2026-07-27T06:21:09.000Z thumbnail image

Stay in the know with updates to Remibrutinib Long-term Extension in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.